Antibody-drug conjugate (ADC): Providing clarity to complex cancer therapy development
3 October 2024
Break through with focused insight
Support with developing an ADC targeted chemotherapy and CDx enabled a sponsor to navigate therapy complexity, global trial design and patient selection for a breakthrough cancer treatment.
Latest content on antibody-drug conjugates (ADCs)
Case study
Find out how specialized global laboratory support and scientific expertise helped a sponsor navigate complexities in ADC development.
Brochure
Get comprehensive support for your ADC, from discovery through post-commercialization.
ADC
Your ADC journey begins with a vision—one where your drug candidate makes a profound impact on the lives of oncology patients.
Oncology
Your mission is to transform oncology patient care. Our commitment is to help you do it better, faster and more efficiently.